CPS Capital Makes Growth Investment in PharmaSmart International

1315 Capital Backs USpharma Ltd. with Growth Equity Investment

June 30, 2025

Pharmaceuticals

USpharma Ltd., a Miami Lakes-based pharmaceutical development and manufacturing company, received a growth equity investment from Philadelphia-based 1315 Capital. The capital will be used to accelerate development and commercialization of USpharma’s pipeline, expand commercial reach, and scale operations at its 150,000 sq. ft. US-based GMP facility.

K1 Investment Management Invests in Digital Pharmacist

March 11, 2019

Cloud & SaaS

K1 Investment Management made a substantial growth investment (reported over $100 million) in Digital Pharmacist Inc. to help the Austin-based SaaS company scale operations, accelerate product development, and expand its digital patient–pharmacy engagement platform used by thousands of pharmacies. The company will continue to be led by its existing management team while leveraging K1's operational support and capital to consolidate market position.

CPS Capital Takes CloudMD Private

July 9, 2024

Healthcare Services

CPS Capital, through an affiliate, completed a court-approved plan of arrangement to acquire all outstanding common shares of CloudMD Software & Services Inc., taking the company private for C$0.04 per share. The transaction will result in CloudMD being delisted from the TSX Venture Exchange as CPS Capital assumes ownership to pursue growth and operational objectives outside the public markets.

Seven Hills Capital Partners with CPS Infusion to Launch Infusion Therapy Platform

August 1, 2025

Healthcare Services

Seven Hills Capital has made a platform investment in CPS Infusion to form a dedicated outpatient infusion therapy platform. The partnership will support CPS Infusion's growth across the Greater Atlanta area and broader Georgia market, leveraging CPS's seven-location footprint and clinical leadership.

CVC Invests KRW 200 Billion in PharmaResearch to Accelerate Global Expansion

September 5, 2024

Pharmaceuticals

Global private equity firm CVC invested KRW 200 billion in South Korea's PharmaResearch via redeemable convertible preferred shares (RCPS). The minority growth investment will support PharmaResearch’s overseas market entry, strategic M&A activity, and R&D/product pipeline expansion in aesthetic injectables and regenerative medicines.

Nautic Partners Makes Growth Investment in SPS Health

February 4, 2022

Healthcare Services

Nautic Partners has made a strategic growth investment in SPS Health to support the company's continued investment in technology, clinical and operational solutions for post-acute pharmacies and PBMs. The capital from Nautic (from its tenth fund) will help SPS expand its technology-enabled offerings and broaden its reach across long-term care, behavioral health, correctional and other specialty pharmacy markets.